Vaccines

Sep 14, 2016
By Pharmaceutical Technology Editors
The project aims to address challenges facing the development, manufacture, and delivery of vaccines.
Aug 12, 2016
Zika vaccine development is hindered by technical challenges and funding shortfalls.
Jul 27, 2016
The Phase I trial will test Bavarian Nordic’s vaccine, which is manufactured using a vaccine vector based on smallpox.
Jul 25, 2016
The vaccine candidate has also won a Priority Medicines (PRIME) status from EMA.
Jun 28, 2016
By Pharmaceutical Technology Editors
MilliporeSigma and the International Vaccine Institute in Seoul, South Korea aim to develop more robust, scalable vaccine manufacturing processes.
Jun 28, 2016
Antibodies to dengue may either confer protective immunity to the Zika virus or enhance disease severity in secondary, related infections such as Zika.
Jun 23, 2016
Studying broadly neutralizing antibodies in infants may lead to new pathways in HIV vaccine development.
Jun 16, 2016
A new indication for Emergent BioSolutions’ BioThrax will give the drug market exclusivity through November 2022.
Jun 13, 2016
By Pharmaceutical Technology Editors
FDA approved Vaxchora intended for travelers who are at risk for the disease.
Jun 09, 2016
The inactivated vaccine, manufactured with a GE FlexFactory system, could be associated with fewer adverse reactions than the live vaccine option.
native1_300x100
lorem ipsum